Erratum: Expression of Concern: DNA Persistence and Relapses Questions on the Treatment Strategies of Enterococcus Infections of Prosthetic Valves (PLoS ONE (2012) 7:12 (e53335) DOI: 10.1371/journal.pone.0053335);DNA Persistence and Relapses Questions on the Treatment Strategies of Enterococcus Infections of Prosthetic Valves

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Casalta, Jean Paul ^a   Thuny, Franck ^b   Fournier, Pierre Edouard ^a   Lepidi, Hubert ^a   Habib, Gilbert ^b   Grisoli, Dominique ^b   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RNA 16S;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM DETECTION; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; GENE AMPLIFICATION; HEART VALVE PROSTHESIS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MORBIDITY; PERSISTENT INFECTION; PROSTHETIC VALVE ENDOCARDITIS; RELAPSE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS MUTANS; TREATMENT DURATION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 84871744004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0278739     Document Type: Erratum

References (34)

1. Chu VH, Sexton DJ, Cabell CH, Reller LB, Pappas PA, et al. (2005) Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 41: 406-409.
2. Mansur AJ, Dal Bo CM, Fukushima JT, Issa VS, Grinberg M, et al. (2001) Relapses, recurrence, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J 141: 78-86.
3. Potron A, Mainardi JL, Podglajen I, Meunier F, Sanson-le Pors MJ, et al. (2010) Recurrent infective endocarditis due to Aggregatibacter actinomycetemcomitans: reinfection or relapse? J Med Microbiol 59: 1524-1526.
4. Voldstedlund M, Nørum Pedersen L, Baandrup U, Klaaborg KE, Fuursted K, (2008) Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. APMIS 116: 190-198.
5. Vollmer T, Piper C, Horstkotte D, Körfer R, Kleesiek K, et al. (2001) 23S rDNA real-time polymerase chain reaction of heart valves: a decisive tool in the diagnosis of infective endocarditis. Eur Heart J 31: 1105-1113.
6. Greub G, Lepidi H, Rovery C, Casalta JP, Habib G, et al. (2005) Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 118: 230-238.
7. Rovery C, Greub G, Lepidi H, Casalta H, Habib G, et al. (2005) PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43: 163-167.
8. Lang S, Watkin RW, Lambert PA, Bonser RS, Littler WA, et al. (2004) Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect 48: 269-275.
9. Fournier PE, Raoult D, (1999) Nonculture laboratory methods for the diagnosis of infectious endocarditis. Curr Infect Dis Rep 1: 136-141.
10. Fournier PE, Casalta JP, Habib G, Messana T, Raoult D, (1992) Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 100: 629-633.
11. Houpikian P, Raoult D, (2002) Diagnostic methods: current best practices and guidelines for identification of difficult-to-culture pathogens. Infect Dis Clin N Am 16: 377-392.
12. Li JS, Sexton DJ, Mick N, Nettles R, FowlerVGJ, et al, (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633-638.
13. Casalta JP, Gouriet F, Thuny F, Bothelo E, Lepidi H, et al. (2009) Standardization and multidisciplinary coverage of endocardites. Strategy of the CHU of Marseille. Antibiotiques 11: 81-89.
14. Hoen B, Thuny F, Prendergast B, Vilacosta I, Moreillon P, et al. (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30: 2369-2413.
15. Lepidi H, Durack DT, Raoult D, (2002) Diagnostic methods: current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin N Am 16: 339-361.
16. Verheul HA, van den Brink RB, van Vreeland T, Moulijn AC, Düren DR, et al. (1993) Effects of changes in management of active infective endocarditis on outcome in a 25-year period Am J Cardiol. 72: 682-687.
17. Tornos MP, Permanyer-Miralda G, Olona M, Gil M, Galve E, et al. (1992) Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med 117: 567-572.
18. Jovanović M, Pelemis M, Pavlović M, Stosović B, Tosić T, et al. (2010) Recidivant endocarditis: report of two cases J Heart Valve Dis. 19: 540-541.
19. Talarmin JP, Pineau S, Guillouzouic A, Boutoille D, Giraudeau C, et al. (2011) Relapse of Enterococcus hirae prosthetic valve endocarditis. J Clin Microbiol 49: 1182-1184.
20. Fernández Guerrero ML, Goyenechea A, Verdejo C, Roblas RF, de Górgolas M, (2007) Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome. Medicine (Baltimore) 86: 363-377.
21. Olaison L, Schadewitz K, (2002) Enterococcal endocarditis in Sweden, 1995-1999: Can shorter therapy with aminoglycosides be used? Clin Infect Dis 34: 159-166.
22. Mandell GL, Benett JE, Rolin R, (2000) Enterococcus species, Streptococcus bovis, and Leuconostoc species in Principles and practices of infectious diseases. Fifth edition. vol 2 chap (189):: 2147-2155.
23. Ho HH, Siu CW, Yiu KH, Tse HF, Chui WH, et al. (2010) Prosthetic valve endocarditis in a multicenter registry of Chinese patients. Asian Cardiovasc Thorac Ann 18: 430-434.
24. Cenciarini-Borde C, Courtois S, La Scola B, (2009) Nucleic acids as viability markers for bacteria detection using molecular tools. Future Microbiol 4: 45-64.
25. Truninger K, Attenhofer Jost CH, Seifert B, Vogt PR, Follath F, et al. (1999) Long term follow-up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart 82: 714-720.
26. Yu VL, Fang GD, Keys TF, Harris AA, Gentry LO, et al. (1994) Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 58: 1073-1077.
27. Habib G, Tribouilloy C, Thuny F, Giorgi R, Brahim A, et al. (2005) Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart 91: 954-959.
28. Hunter TH, (1947) Use of Streptomycin in treatment of bacterial endocarditis. Am J Med 2: 436-442.
29. Moellering RC Jr, (1991) The Garrod Lecture: the enterococcus: A classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 28: 1-12.
30. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, et al. (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30: 2369-2413.
31. Habib G, Tribouilloy C, Thuny F, Giorgi R, Brahim A, et al. (2005) Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart 91: 954-959.
32. Jaussaud N, Gariboldi V, Giorgi R, Grisoli D, Chalvignac V, et al. (2009) Risk of reoperation for aortic bioprosthesis dysfunction. J HeartValve Dis 18: 256-261.
33. Jaussaud N, Gariboldi V, Grisoli D, Berbis J, Kerbaul F, et al. (2012) Risk of rreoperation for mitral bioprosthesis dysfunction J Heart Valve Dis. 21: 56-60.
34. Nashef S, Roques F, Michel P, Gauducheau E, Lemeshow S, et al. (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16: 9-13.